Hong Lab Puts Up a Fight Against Drug Resistant Bacteria, Fungal Infections, and Pain

RNAscope in situ hybridization images showing co-localization of SLC29A1 and ADOR1 (A1R) in human DRG (hDRG) neurons
RNAscope in situ hybridization images showing co-localization of SLC29A1 and ADOR1 (A1R) in human DRG (hDRG) neurons

The Hong Lab has teamed up with more than seven different collaborators across multiple institutions in the fight against drug resistant bacteria, taking on the tough target of fungal infections through modified natural products, and to develop novel non-opioid pain medications. Their recent work has been featured in Nature Communications, the Proceedings of the National Academy of Sciences, and JACS Au. 

To learn more about how the Hong Lab is combatting drug-resistant gram-negative bacteria, take a look here

For more information on their promising therapeutic target for pain relief and the development of non-addictive pain medications, click here.

Finally, follow along here to discover how the Hong Lab is revolutionizing the treatment of fungal infections through natural products.